Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,722 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Why promoting a COVID-19 vaccine booster dose?
Loubet P, Laureillard D, Martin A, Larcher R, Sotto A. Loubet P, et al. Among authors: martin a. Anaesth Crit Care Pain Med. 2021 Dec;40(6):100967. doi: 10.1016/j.accpm.2021.100967. Anaesth Crit Care Pain Med. 2021. PMID: 34924154 Free PMC article. No abstract available.
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.
Gault N, Esposito-Farèse M, Revest M, Inamo J, Cabié A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, De Montmollin E, Oziol E, Etienne M, Laouénan C, Rossignol P, Costagliola D, Vidal-Petiot E; French-Covid cohort investigators, study group. Gault N, et al. Fundam Clin Pharmacol. 2021 Dec;35(6):1141-1158. doi: 10.1111/fcp.12683. Epub 2021 May 16. Fundam Clin Pharmacol. 2021. PMID: 33876439 Free PMC article.
Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
Larcher R, Laffont-Lozes P, Roger C, Doncesco R, Groul-Viaud C, Martin A, Loubet P, Lavigne JP, Pantel A, Sotto A. Larcher R, et al. Among authors: martin a. Front Cell Infect Microbiol. 2022 Dec 5;12:1048633. doi: 10.3389/fcimb.2022.1048633. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36544909 Free PMC article.
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France.
Laffont-Lozes P, Laureillard D, Loubet P, Stephan R, Chiaruzzi M, Clemmer E, Martin A, Roger C, Muller L, Claret PG, Goulabchand R, Roux C, Lavigne JP, Sotto A, Larcher R. Laffont-Lozes P, et al. Among authors: martin a. Antibiotics (Basel). 2023 Jan 4;12(1):88. doi: 10.3390/antibiotics12010088. Antibiotics (Basel). 2023. PMID: 36671288 Free PMC article.
Clinical factors associated with peripherally inserted central catheters (PICC) related bloodstream infections: a single centre retrospective cohort.
Barrigah-Benissan K, Ory J, Simon C, Loubet P, Martin A, Beregi JP, Lavigne JP, Sotto A, Larcher R. Barrigah-Benissan K, et al. Among authors: martin a. Antimicrob Resist Infect Control. 2023 Jan 30;12(1):5. doi: 10.1186/s13756-023-01209-z. Antimicrob Resist Infect Control. 2023. PMID: 36717942 Free PMC article.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Gaborit B, et al. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad525. doi: 10.1093/ofid/ofad525. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37942459 Free PMC article.
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, Nailler L, Boston A, Melenotte C, Cabié A, Choquet C, Coustillères F, Martellosio JP, Gaube G, Trinh-Duc A, Ronchetti AM, Pourcher V, Chauveau M, Lacombe K, Peiffer-Smadja N, Housset P, Perrot A, Pialoux G, Martin A, Dubee V, Devaux M, Frey J, Cazanave C, Liblau R, Carrat F, Yordanov Y. Martin-Blondel G, et al. Among authors: martin a. J Infect. 2022 Oct;85(4):e104-e108. doi: 10.1016/j.jinf.2022.06.033. Epub 2022 Jul 5. J Infect. 2022. PMID: 35803386 Free PMC article. No abstract available.
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir.
Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y. Martin-Blondel G, et al. Among authors: martin a. Clin Microbiol Infect. 2023 Apr;29(4):543.e5-543.e9. doi: 10.1016/j.cmi.2022.12.016. Epub 2022 Dec 28. Clin Microbiol Infect. 2023. PMID: 36586513 Free PMC article.
10,722 results
You have reached the last available page of results. Please see the User Guide for more information.